Comment by qlte

Best on the market, for something not being sold on the market? How is that helpful in terms of actual revenue?

If Anthropic manages to start producing new pharmaceuticals with their internal models or something that thesis could make sense but not if 90% of their revenue comes from enterprise API sales which would necessarily have to be accessible to the public. Which are then inevitably fast followed by Chinese models 3 months later.